ASH 2025: Major treatment overhauls for acute myeloid leukaemia
A new generation of targeted treatments and gentler chemotherapy options for older adults with a…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Scientists can finally answer an old question about cellular ageing
After a finite number of divisions, cells simply give up. As each round of replication…
Australian researchers build new antibody to target cancer cells
A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such…
Potential new treatment for aggressive ovarian cancer
Scientists at The University of Texas, USA, have found a promising new target in the…
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the…
Study identifies target for disease hyper progression after immunotherapy in kidney cancer
Researchers at The University of Texas MD Anderson Cancer Centre, USA, have found that renal…
Much-needed new drug approved for acute myeloid leukaemia
Biomedical research that began at the University of Virginia School of Medicine, USA, has yielded…
Researchers identify why some lung tumours respond well to immunotherapy
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new…
AI tops density in predicting breast cancer risk
An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided…
Patient-reported outcomes in cancer clinical trials
The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI),…